Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Daniela Pugliese, Carla Felice, Alfredo Papa, Antonio Gasbarrini, Gian Lodovico Rapaccini, Luisa Guidi & Alessandro Armuzzi. (2017) Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future. Expert Review of Clinical Immunology 13:3, pages 223-233.
Read now
Read now
Articles from other publishers (36)
Chenquan Gan, Jiabin Lin, Da-Wen Huang, Qingyi Zhu & Liang Tian. (2023) Advanced Persistent Threats and Their Defense Methods in Industrial Internet of Things: A Survey. Mathematics 11:14, pages 3115.
Crossref
Crossref
Sally Mortlock, Anton Lord, Grant Montgomery, Martha Zakrzewski, Lisa A Simms, Krupa Krishnaprasad, Katherine Hanigan, James D Doecke, Alissa Walsh, Ian C Lawrance, Peter A Bampton, Jane M Andrews, Gillian Mahy, Susan J Connor, Miles P Sparrow, Sally Bell, Timothy H Florin, Jakob Begun, Richard B Gearry & Graham L Radford-Smith. (2023) An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis. Journal of Crohn's and Colitis 17:2, pages 277-288.
Crossref
Crossref
Sophie Vieujean & Edouard Louis. (2023) Precision medicine and drug optimization in adult inflammatory bowel disease patients. Therapeutic Advances in Gastroenterology 16, pages 175628482311733.
Crossref
Crossref
Nick Dai, Omar Haidar, Alan Askari & Jonathan P Segal. (2023) Colectomy rates in ulcerative colitis: A systematic review and meta-analysis. Digestive and Liver Disease 55:1, pages 13-20.
Crossref
Crossref
Megan E. Murphy, Sumona Bhattacharya & Jordan E. Axelrad. (2022) Diagnosis and Monitoring of Ulcerative Colitis. Clinics in Colon and Rectal Surgery 35:06, pages 421-427.
Crossref
Crossref
Bram Verstockt, Brian Bressler, Helena Martinez-Lozano, Dermot McGovern & Mark S. Silverberg. (2022) Time to Revisit Disease Classification in Inflammatory Bowel Disease: Is the Current Classification of Inflammatory Bowel Disease Good Enough for Optimal Clinical Management?. Gastroenterology 162:5, pages 1370-1382.
Crossref
Crossref
Elena De Cristofaro, Silvia Salvatori, Irene Marafini, Francesca Zorzi, Norma Alfieri, Martina Musumeci, Emma Calabrese & Giovanni Monteleone. (2022) Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab. Journal of Clinical Medicine 11:6, pages 1679.
Crossref
Crossref
Carsten Schmidt, Bernd Bokemeyer, Andreas Lügering, Dominik Bettenworth, Niels Teich, Imma Fischer, Leonie Hammer, Stefanie Kolterer, Stefan Rath & Andreas Stallmach. (2022) Clinical predictors for a complicated course of disease in an inception cohort of patients with ulcerative colitis: results from the prospective, observational EPICOL study. International Journal of Colorectal Disease 37:2, pages 485-493.
Crossref
Crossref
Jian Wan, Xuan Wang, Yujie Zhang, Xianmin Xue, Hui Jia, Min Wang, Jie Liang & Kaichun Wu. (2022) Time-adjusted average Mayo endoscopic score predicts the risk of disease extent progression in distal ulcerative colitis patients. Gastroenterology Report 10.
Crossref
Crossref
Maryam Zafer, Hui Zhang, Sujaata Dwadasi, Donald Goens, Raghavendra Paknikar, Sushila Dalal, Russell D Cohen, Joel Pekow, David T Rubin, Atsushi Sakuraba & Dejan Micic. (2022) A Clinical Predictive Model for One-year Colectomy in Adults Hospitalized for Severe Ulcerative Colitis. Crohn's & Colitis 360 4:1.
Crossref
Crossref
Henriette Jahre, Margreth Grotle, Milada Småstuen, Maren Hjelle Guddal, Kaja Smedbråten, Kåre Rønn Richardsen, Synne Stensland, Kjersti Storheim & Britt Elin Øiestad. (2021) Risk factors and risk profiles for neck pain in young adults: Prospective analyses from adolescence to young adulthood—The North-Trøndelag Health Study. PLOS ONE 16:8, pages e0256006.
Crossref
Crossref
Jared Matson, Sonia Ramamoorthy & Nicole E. Lopez. (2021) The Role of Biomarkers in Surgery for Ulcerative Colitis: A Review. Journal of Clinical Medicine 10:15, pages 3362.
Crossref
Crossref
Yong Il Lee, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim & Jae Hee Cheon. (2021) Comparison of Long-Term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis. Gut and Liver 15:2, pages 232-242.
Crossref
Crossref
Jon R. Florholmen, Kay-Martin Johnsen, Renate Meyer, Trine Olsen, Øystein K. Moe, Petter Tandberg, Mona D. Gundersen, Jan-Magnus Kvamme, Knut Johnsen, Terje Løitegård, Gabriele Raschpichler, Cecilia Vold, Sveinung W. Sørbye & Rasmus Goll. (2020) Discovery and validation of mucosal TNF expression combined with histological score - a biomarker for personalized treatment in ulcerative colitis. BMC Gastroenterology 20:1.
Crossref
Crossref
Robert Salameh, Julien Kirchgesner, Matthieu Allez, Franck Carbonnel, Antoine Meyer, Jean-Marc Gornet, Laurent Beaugerie & Aurelien Amiot. (2020) Long-term outcome of patients with acute severe ulcerative colitis responding to intravenous steroids. Alimentary Pharmacology & Therapeutics 51:11, pages 1096-1104.
Crossref
Crossref
Millie D Long, Timothy W Smith, Marco Dibonaventura, David Gruben, Danielle Bargo, Leonardo Salese & Daniel Quirk. (2020) Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States. Inflammatory Bowel Diseases 26:6, pages 941-948.
Crossref
Crossref
Ivar Magne Austevoll, Erland Hermansen, Morten Fagerland, Frode Rekeland, Tore Solberg, Kjersti Storheim, Jens Ivar Brox, Greger Lønne, Kari Indrekvam, Jørn Aaen, Oliver Grundnes & Christian Hellum. (2019) Decompression alone versus decompression with instrumental fusion the NORDSTEN degenerative spondylolisthesis trial (NORDSTEN-DS); study protocol for a randomized controlled trial. BMC Musculoskeletal Disorders 20:1.
Crossref
Crossref
Lorant Gonczi, Talat Bessissow & Peter Laszlo Lakatos. (2019) Disease monitoring strategies in inflammatory bowel diseases: What do we mean by ‘tight control’?. World Journal of Gastroenterology 25:41, pages 6172-6189.
Crossref
Crossref
Samantha Webster. (2019) Defining the Future of Inflammatory Bowel Disease Care: The Pivotal Role of Personalised Treatment. EMJ Gastroenterology, pages 2-10.
Crossref
Crossref
Christopher R. Lindholm & Corey A. Siegel. (2019) Are We Ready to Include Prognostic Factors in Inflammatory Bowel Disease Trials?. Current Pharmaceutical Design 25:1, pages 64-68.
Crossref
Crossref
Lee A Denson, Mark Curran, Dermot P B McGovern, Walter A Koltun, Richard H Duerr, Sandra C Kim, R Balfour Sartor, Francisco A Sylvester, Clara Abraham, Edwin F de Zoeten, Corey A Siegel, Richéal M Burns, Angela M Dobes, Nataly Shtraizent, Gerard Honig, Caren A Heller, Andrés Hurtado-Lorenzo & Judy H Cho. (2019) Challenges in IBD Research: Precision Medicine. Inflammatory Bowel Diseases 25:Supplement_2, pages S31-S39.
Crossref
Crossref
Fabio Salvatore Macaluso, Flaminia Cavallaro, Carla Felice, Marta Mazza, Alessandro Armuzzi, Paolo Gionchetti, Maurizio Vecchi & Ambrogio Orlando. (2019) Risk factors and timing for colectomy in chronically active refractory ulcerative colitis: A systematic review. Digestive and Liver Disease 51:5, pages 613-620.
Crossref
Crossref
David T. Rubin, Ashwin N. Ananthakrishnan, Corey A. Siegel, Bryan G. Sauer & Millie D. Long. (2019) ACG Clinical Guideline: Ulcerative Colitis in Adults. American Journal of Gastroenterology 114:3, pages 384-413.
Crossref
Crossref
Evangelos Messaris & Themistocles Dassopoulos. 2019. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set
1888
1918
.
Jason Reinglas, Lorant Gonczi, Zsuzsanna Kurt, Talat Bessissow & Peter L Lakatos. (2018) Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases. World Journal of Gastroenterology 24:32, pages 3567-3582.
Crossref
Crossref
Lydia C T Buer, Marte L Høivik, David J Warren, Asle W Medhus & Bjørn A Moum. (2018) Combining Anti-TNF-α and Vedolizumab in the Treatment of Inflammatory Bowel Disease: A Case Series. Inflammatory Bowel Diseases 24:5, pages 997-1004.
Crossref
Crossref
Rohini Vanga & Millie D. Long. (2018) Contemporary Management of Ulcerative Colitis. Current Gastroenterology Reports 20:3.
Crossref
Crossref
Mathurin Flamant & Xavier Roblin. (2018) Inflammatory bowel disease: towards a personalized medicine. Therapeutic Advances in Gastroenterology 11, pages 1756283X1774502.
Crossref
Crossref
Daniel P. Ryan & Daniel P. Doody. (2017) Surgical options in the treatment of ulcerative colitis. Seminars in Pediatric Surgery 26:6, pages 379-383.
Crossref
Crossref
Janet Fricker. (2017) Changing the Game in Ulcerative Colitis: The Impact of Gut-Selective Therapy. EMJ Gastroenterology, pages 2-10.
Crossref
Crossref
Ryan Ungaro, Saurabh Mehandru, Patrick B Allen, Laurent Peyrin-Biroulet & Jean-Frédéric Colombel. (2017) Ulcerative colitis. The Lancet 389:10080, pages 1756-1770.
Crossref
Crossref
Nikos Viazis, Marios Giakoumis, Giorgos Bamias, Dimitris Goukos, Theodoros Koukouratos, Konstantina Katopodi, Pantelis Karatzas, Christos Triantos, Chrisostomos Tsolias, Georgios Theocharis, George L. Daikos, Spyros D. Ladas, Dimitrios G. Karamanolis & Gerasimos J. Mantzaris. (2017) Predictors of tissue healing in ulcerative colitis patients treated with anti-TNF. Digestive and Liver Disease 49:1, pages 29-33.
Crossref
Crossref
Mark Silverberg & Sarah O’Donnell. 2017. Inflammatory Bowel Disease. Inflammatory Bowel Disease
29
44
.
Edward L. Barnes & Robert Burakoff. (2016) New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes. Inflammatory Bowel Diseases 22:12, pages 2956-2965.
Crossref
Crossref
Miranda Muhvić-Urek, Marija Tomac-Stojmenović & Brankica Mijandrušić-Sinčić. (2016) Oral pathology in inflammatory bowel disease. World Journal of Gastroenterology 22:25, pages 5655.
Crossref
Crossref
Lauri Arnstein. (2015) Achieving Treatment Goals in Inflammatory Bowel Disease: The Role of Gut-Selective Therapy. EMJ Gastroenterology, pages 40-49.
Crossref
Crossref